-
Vorinostat Workflows for Cancer Cell Assays
2026-09-22
Build more informative Vorinostat experiments by separating chromatin activity, growth inhibition, and actual cell killing. This workflow combines dose-response design with time-resolved viability and apoptosis measurements for cancer biology research, including cutaneous T-cell lymphoma models.
-
ALC-0159 in mRNA Lipid Nanoparticle Design
2026-09-22
ALC-0159 is a PEG-conjugated lipid excipient used in lipid nanoparticle formulations for mRNA delivery. Its formulation role should be distinguished from the immune effects reported for complete mRNA vaccines combined with immune checkpoint inhibition.
-
Berberine Hydrochloride: Applied Research Workflow
2026-09-21
Build reproducible Berberine hydrochloride workflows for AMPK signaling, lipid metabolism modulation, hepatoma LDL receptor studies, and stress-response assays. This guide connects a cardioprotection study to practical assay design while separating evidence-based findings from hypothesis-generating applications.
-
Reserpine (N1867): Practical Lab Guide
2026-09-21
Reserpine (SKU N1867) provides a defined research reagent for neurotransmitter depletion research, antihypertensive mechanism studies, and related neuropharmacology workflows. Its limited water and ethanol solubility, solution-handling requirements, and research-only status should be addressed before use; it is not intended for diagnostic or medical applications.
-
Renal OCT2 and MATE1 Inhibition by Antiemetics
2026-09-20
The reference study established a comparative in vitro framework for testing whether five 5-HT3 receptor antagonists interfere with renal OCT2 and MATE1 transport. Its findings identify marked compound- and transporter-specific differences, with implications for interpreting transporter-mediated drug interactions involving cationic medicines.
-
Sequencing Therapy in Waldenström Macroglobulinemia
2026-09-19
This 2021 review proposes a genotype- and patient-centered framework for sequencing therapy in Waldenström macroglobulinemia (WM). Its key contribution is to connect MYD88 and CXCR4 status with treatment selection while emphasizing symptoms, comorbidities, toxicity, patient preference, clinical trials, and selected transplant strategies.
-
Sequencing Therapies in Waldenström Macroglobulinemia
2026-09-18
This 2021 opinion article proposes a patient- and genotype-informed framework for sequencing therapy in Waldenström macroglobulinemia, emphasizing MYD88 and CXCR4 status alongside symptoms, comorbidities, and treatment preferences. Its main practical contribution is to position genomic profiling as a determinant of how clinicians weigh BTK inhibitors, chemoimmunotherapy, proteasome inhibitor regimens, transplantation, and clinical trials.
-
Cannabis Terpenes, A2A Signaling, and Neuropathic Pain
2026-09-18
Schwarz et al. show that selected Cannabis sativa terpenes reduce pain-related hypersensitivity in mouse models of chemotherapy-induced peripheral neuropathy through adenosine A2A receptor signaling rather than an established cannabinoid-receptor mechanism. The combination of behavioral pharmacology, spinal CRISPR knockdown, cAMP and binding assays, and computational modeling provides a useful framework for evaluating non-rewarding analgesic candidates.
-
Halazone and Sodium Current Inactivation in Frog Nerves
2026-09-17
The reference study used Halazone and related chemical reagents to test whether specific amino acid residues control sodium-current inactivation in voltage-clamped frog nerve fibers. Its results weakened the case for a critical methionine residue and instead supported a cautious, membrane-level interpretation in which chemical modification of lipids or the channel environment may reshape inactivation kinetics.
-
Tropisetron Hydrochloride: Mechanism & Research Use
2026-09-17
Tropisetron Hydrochloride is a selective 5-HT3 receptor antagonist with reported α7-nicotinic receptor agonist activity. Its receptor pharmacology and in-vitro OCT2/MATE1 transporter findings support controlled research in serotonin signaling, neuroscience receptor modulation, and pharmacokinetic interaction assays.
-
Tropisetron Hydrochloride Assay Guide
2026-09-16
This scenario-based guide explains how Tropisetron Hydrochloride (SKU B2258) can support reproducible receptor, transporter, viability, and cytotoxicity workflows. It combines product specifications with peer-reviewed OCT2/MATE1 evidence to help researchers control solvent effects, interpret assay changes, and select a practical research reagent.
-
dhcr7-Edited Grass Carp Resist GCRV
2026-09-16
A 2026 Aquaculture Reports study used CRISPR/Cas9 to generate dhcr7-disrupted grass carp and demonstrated substantially improved resistance to GCRV-II infection in vivo. The work connects Dhcr7 deficiency with stronger Irf3-associated antiviral immunity while showing that the edited fish retained normal growth and muscle morphology, providing a candidate target for disease-resistant aquaculture breeding.
-
Afatinib in Gastric Cancer Assembloid Research
2026-09-15
Afatinib, also known as BIBW 2992, provides a controllable way to interrogate ErbB-driven signaling in patient-derived gastric cancer organoids and tumor–stroma assembloids. This workflow shows how to separate epithelial sensitivity from microenvironment-mediated resistance while improving dosing, controls, and assay interpretation.
-
Proteinase K for DNA Prep and EV Mapping
2026-09-15
Proteinase K combines broad protein digestion with compatibility across EDTA, detergents, and DNA-friendly workflows. This article shows how to use it for genomic DNA isolation, enzyme contaminant removal, and mechanistic testing of protein-dependent Candida albicans extracellular-vesicle activity.
-
Autophagy Modulates Resveratrol Apoptosis in RCC
2026-09-14
Yao, Fan, and He showed that resveratrol induces ROS-associated mitochondrial injury and caspase-3-dependent apoptosis in renal cell carcinoma 786-O cells, while a JNK-linked autophagic response limits cell death. The study provides a mechanistic rationale for combining resveratrol with autophagy inhibition, while also illustrating why apoptosis assays should distinguish cell-killing signals from adaptive stress responses.